Scientists are developing and validating a patent-pending novel immunotherapy to be used against glioblastoma brain tumors. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
Purdue University researchers are developing and validating a patent-pending treatment for incurable glioblastoma brain tumor s. Glioblastomas are almost always lethal with a median survival time of 14 months. Traditional methods used against other cancers, like chemotherapy and immunotherapy, are often ineffective on glioblastoma.
"Our preclinical studies showed these immune cells to be particularly remarkable in targeting and completely eliminating the growth of the tumors," Matosevic said."We found that we can engineer these cells at doses suitable for clinical use in humans. This is significant because one of the major hurdles to clinical translation of cell-based therapies to humans has been the poor expansion and lack of potency of cells that were sourced directly from patients.
"We are working with neurosurgical clinician collaborators to not only obtain funding, but also initiate clinical protocols," he added."We are also open to and always seeking new collaborations and partnerships with those who have interest in supporting our mission to translate this therapy to the clinic, where it is needed the most."
Immune System Stem Cells Lymphoma Dementia Brain-Computer Interfaces Neuroscience Depression
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Get ready for the robotic fish revolutionScientists say swarms of robotic fish could soon make traditional underwater research vehicles obsolete.
Read more »
Experts Back Mexico's Ban on Genetically Modified Corn Amid US Trade DisputeThe Biden administration is challenging the ban in a dispute settlement panel under a North American trade deal.
Read more »
Watch your garden glow with new genetically modified bioluminescent petuniasResearch into new pharmaceuticals has produced an unanticipated by-product: Petunias that glow in the dark
Read more »
Watch your garden glow with new genetically modified bioluminescent petuniasResearch into new pharmaceuticals has produced an unanticipated by-product: Petunias that glow in the dark
Read more »
Man Discharged from Hospital After Receiving Genetically Edited Pig KidneyRichard Slayman, the first living person to receive a genetically edited pig kidney, has been discharged from the hospital after his groundbreaking procedure. Now, he faces the challenge of ensuring the success of his transplanted organ.
Read more »
Richard Slayman Discharged from Hospital After Receiving Genetically Edited Pig KidneyRichard Slayman, the first living person to receive a genetically edited pig kidney, has been discharged from the hospital after his groundbreaking procedure. Now, the focus is on ensuring the success of his transplanted organ.
Read more »